A citation-based method for searching scientific literature

Atsushi Mikada, Takuma Narita, Hiroki Yokoyama, Risa Yamashita, Yohei Horikawa, Katsushi Tsukiyama, Yuichiro Yamada. Diabetes Res Clin Pract 2014
Times Cited: 17







List of co-cited articles
78 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
A Lee, P Patrick, J Wishart, M Horowitz, J E Morley. Diabetes Obes Metab 2002
123
29

Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
610
23

Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients.
T Narita, H Yokoyama, R Yamashita, T Sato, M Hosoba, T Morii, H Fujita, K Tsukiyama, Y Yamada. Diabetes Obes Metab 2012
50
23

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.
C Pan, W Yang, J P Barona, Y Wang, M Niggli, P Mohideen, Y Wang, J E Foley. Diabet Med 2008
124
17

Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
268
17


Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
Kazutaka Aoki, Kiyomi Masuda, Takashi Miyazaki, Yu Togashi, Yasuo Terauchi. Endocr J 2010
36
17

Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
Masayuki Arakawa, Chie Ebato, Tomoya Mita, Yoshio Fujitani, Tomoaki Shimizu, Hirotaka Watada, Ryuzo Kawamori, Takahisa Hirose. Metabolism 2008
59
17

Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
Gary A Herman, Arthur Bergman, Catherine Stevens, Paul Kotey, Bingming Yi, Peng Zhao, Bruno Dietrich, George Golor, Andreas Schrodter, Bart Keymeulen,[...]. J Clin Endocrinol Metab 2006
382
17

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
Floris A van de Laar, Peter L Lucassen, Reinier P Akkermans, Eloy H van de Lisdonk, Guy E Rutten, Chris van Weel. Diabetes Care 2005
345
17



Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Fuminori Tatsumi, Mitsuru Hashiramoto, Hidenori Hirukawa, Tomohiko Kimura, Masashi Shimoda, Kazuhito Tawaramoto, Yukiko Kanda-Kimura, Takatoshi Anno, Fumiko Kawasaki, Tomoatsu Mune,[...]. Diabetes Res Clin Pract 2013
7
42

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
17



Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial.
Y Iwamoto, N Tajima, T Kadowaki, K Nonaka, T Taniguchi, M Nishii, J C Arjona Ferreira, J M Amatruda. Diabetes Obes Metab 2010
83
11


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
11

DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.
Kazufumi Nakamura, Hiroki Oe, Hajime Kihara, Kenei Shimada, Shota Fukuda, Kyoko Watanabe, Tsutomu Takagi, Kei Yunoki, Toru Miyoshi, Kumiko Hirata,[...]. Cardiovasc Diabetol 2014
88
11


GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Paula L McClean, Nigel Irwin, Roslyn S Cassidy, Jens J Holst, Victor A Gault, Peter R Flatt. Am J Physiol Endocrinol Metab 2007
178
11

Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus.
Kenta Okada, Hiroaki Yagyu, Kazuhiko Kotani, Hisataka Yamazaki, Kazufumi Ozaki, Manabu Takahashi, Shuichi Nagashima, Jun-Ichi Osuga, Shun Ishibashi. Endocr J 2013
6
33


Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Daniela Lamers, Susanne Famulla, Nina Wronkowitz, Sonja Hartwig, Stefan Lehr, D Margriet Ouwens, Kristin Eckardt, Jean M Kaufman, Mikael Ryden, Stefan Müller,[...]. Diabetes 2011
378
11

Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes.
Hitoshi Sugihara, Mototsugu Nagao, Taro Harada, Yasushi Nakajima, Kyoko Tanimura-Inagaki, Fumitaka Okajima, Hideki Tamura, Takeshi Inazawa, Takatoshi Otonari, Masanobu Kawakami,[...]. J Diabetes Investig 2014
23
11


Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
L K Campbell, D E Baker, R K Campbell. Ann Pharmacother 2000
45
11

The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Yoji Hamada, Hiroshi Nagasaki, Masahiro Fuchigami, Shinji Furuta, Yusuke Seino, Jiro Nakamura, Yutaka Oiso. Metabolism 2013
19
11


Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
K Aoki, S Nakajima, U Nezu, K Shinoda, Y Terauchi. Diabetes Obes Metab 2008
13
15

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
11


Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients.
Kazutaka Aoki, Akinobu Nakamura, Satoshi Ito, Uru Nezu, Tomoyuki Iwasaki, Mayumi Takahashi, Mari Kimura, Yasuo Terauchi. Diabetes Res Clin Pract 2007
22
11


Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
Seiya Shimoda, Shinsuke Iwashita, Taiji Sekigami, Noboru Furukawa, Yasuto Matsuo, Shinji Ichimori, Rieko Goto, Takako Maeda, Eiichiro Watanabe, Tatsuya Kondo,[...]. J Diabetes Investig 2014
8
25

Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
Giuseppe Derosa, Pietro D Ragonesi, Anna Carbone, Elena Fogari, Lucio Bianchi, Aldo Bonaventura, Davide Romano, Arrigo F G Cicero, Pamela Maffioli. Diabetes Technol Ther 2012
41
11

Plasma adiponectin levels and risk of myocardial infarction in men.
Tobias Pischon, Cynthia J Girman, Gokhan S Hotamisligil, Nader Rifai, Frank B Hu, Eric B Rimm. JAMA 2004
11

The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes.
Yoshiaki Kubota, Masaaki Miyamoto, Gen Takagi, Takeshi Ikeda, Sonoko Kirinoki-Ichikawa, Kotoko Tanaka, Kyoichi Mizuno. J Korean Med Sci 2012
64
11


Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Giuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, Ilaria Ferrari, Pietro D Ragonesi, Fabrizio Querci, Ivano G Franzetti, Gennaro Gadaleta, Leonardina Ciccarelli, Mario N Piccinni,[...]. Metabolism 2010
90
11

Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus.
T Forst, M Dworak, C Berndt-Zipfel, A Löffler, I Klamp, M Mitry, A Pfützner. Diabetes Obes Metab 2013
16
12

A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus--a randomized controlled trial START-J study.
Toshiyuki Hibuse, Norikazu Maeda, Ken Kishida, Takekazu Kimura, Tomoko Minami, Eriko Takeshita, Ayumu Hirata, Yasuhiko Nakagawa, Susumu Kashine, Akemi Oka,[...]. Cardiovasc Diabetol 2014
21
11

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.
Giuseppe Derosa, Anna Carbone, Ivano Franzetti, Fabrizio Querci, Elena Fogari, Lucio Bianchi, Aldo Bonaventura, Davide Romano, Arrigo F G Cicero, Pamela Maffioli. Diabetes Res Clin Pract 2012
49
11

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.
Le Thi Kim Chung, Toshio Hosaka, Masaki Yoshida, Nagakatsu Harada, Hiroshi Sakaue, Tohru Sakai, Yutaka Nakaya. Biochem Biophys Res Commun 2009
91
11



Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
11

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
11

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.